ARCHIVE

• Teijin Pharma to Be Firmly Set Up: Mr Ohyagi
  June 23, 2003

• Current NHI Pricing Rule's Perfection Level Is High: Mr Yashiro
  June 23, 2003

• Meiji, Solvay File for Social Anxiety as New Indication for SSRI Fluvoxamine
  June 23, 2003

• BULLETIN
  June 23, 2003

• Kuraya Sanseido to Cut Costs Without Undermining Marketing Ability
  June 23, 2003

• WORLD NEWS IN BRIEF
  June 23, 2003

• BUSINESS NEWS IN BRIEF
  June 23, 2003

• Press Seminar
  June 23, 2003

• WEBSITE NEWS
  June 23, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  June 23, 2003

• NEW PRODUCTS
  June 23, 2003

• Antihyperlipidemics Finds High Support for Mevalotin: Epoka's Survey
  June 16, 2003

• Astem Forest: Sales Up 2.0% to \298 Bil., Net Profits Up 26.5% to \1.99 Bil.
  June 16, 2003

• Recent Proposals Would Hinder Promotion of GE Use: GE Makers Group
  June 16, 2003

• VITAL-NET: Sales Up 3.6%, Profits Boost
  June 16, 2003

• NEW PRODUCTS
  June 16, 2003

• Kobayashi Pharmaceutical: Sales Up 3.1%, Net Profits Up 0.2%
  June 16, 2003

• BUSINESS NEWS IN BRIEF
  June 16, 2003

• SSP: Sales of Self-medication Products Decline due to Slump of Major Products
  June 16, 2003

• WEBSITE NEWS
  June 16, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 591
• 592
• 593
• 594
• 595
• 596
• 597
• 598
• 599
• …
• Next ›
• 最終 »